Showing 672 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

SA can save billions with new HIV drug combination

Editor's pick
Health24
17 January 2017
Changing treatment

GlaxoSmithKline’s New Drug Challenges HIV Treatment Orthodoxy

Editor's pick
Wall Street Journal
20 December 2016
New & experimental HIV treatments

Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen

Editor's pick
Janssen press release
20 December 2016
New & experimental HIV treatments

Charlie Sheen Achieves Undetectable Viral Load With Weekly Injectable HIV Treatment

Editor's pick
The Body
8 December 2016
HIV treatment

Top 10 HIV Clinical Developments of 2016

Editor's pick
The Body Pro
2 December 2016
New & experimental HIV treatments

China to approve 1st long-acting injection to treat HIV/AIDS

Editor's pick
Global Times
25 November 2016
New & experimental HIV treatments

ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen

Editor's pick
ViiV press release
21 November 2016
Pharmaceutical industry

‘Hard’ Brexit would delay access to new drugs, warns report

Editor's pick
Pharma Times
9 November 2016
Pharmaceutical industry

GSK discontinues development of maturation inhibitor BMS-986173

Editor's pick
HIV i-Base
31 October 2016
PrEP

Two Thirds of Oral PrEP-Using MSM Would Switch to Long-Term Shots

Editor's pick
NATAP
26 October 2016
PrEP

More Surprises From ÉCLAIR: Cabotegravir's 'Long Tail'

Editor's pick
Medscape (requires free registration)
26 October 2016
New & experimental HIV treatments

New nanomedicine approach aims to improve HIV drug therapies

Editor's pick
Science Daily
24 October 2016
Changing treatment

Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

Editor's pick
BETA blog
20 September 2016
Pharmaceutical industry

Janssen Submits Marketing Authorisation Application for Darunavir-Based Single Tablet Regimen for Treatment of HIV-1 to European Medicines Agency

Editor's pick
Janssen-Cilag press release
13 September 2016
Pharmaceutical industry

Glaxo Bets It Can Shake Up HIV Treatment

Editor's pick
Wall Street Journal
30 August 2016
New & experimental HIV treatments

Emtricitabine/tenofovir alafenamide in HIV infection: Added benefit not proven

Editor's pick
German Institute for Quality and Efficiency in Health Care
19 August 2016
Pharmaceutical industry

German agency criticises European programme for speeding some drug approvals

Editor's pick
STAT
18 August 2016
New & experimental HIV treatments

ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment

Editor's pick
ViiV press release
16 August 2016
New & experimental HIV treatments

Treatment Action Group: Pipeline Report 2016

Editor's pick
Treatment Action Group
15 July 2016
New & experimental HIV treatments

The HIV Treatment Pipeline

Editor's pick
Poz
28 June 2016
New & experimental HIV treatments

Gilead’s single tablet regimen Odefsey receives European marketing approval for HIV treatment

Editor's pick
PharmaBiz
27 June 2016
New & experimental HIV treatments

Investigational Integrase Inhibitor Bictegravir Safe and Effective Against HIV in Early Study

Editor's pick
The Body
21 June 2016
New & experimental HIV treatments

Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial

Editor's pick
Frontier Biotech press release
7 June 2016
Access to healthcare

Botswana gets GSK's modern HIV drug in largest ever Africa tender

Editor's pick
Reuters
3 June 2016